Antiretroviral News and Research

RSS
FDA approves first injectable, complete regimen for HIV-1 infection in adults

FDA approves first injectable, complete regimen for HIV-1 infection in adults

Researchers measure brain volume differences in HIV-infected individuals

Researchers measure brain volume differences in HIV-infected individuals

Scientists determine ideal dose of stem cells to control HIV

Scientists determine ideal dose of stem cells to control HIV

Impaired blood vessel and kidney function underlie heart disease risk in people with HIV

Impaired blood vessel and kidney function underlie heart disease risk in people with HIV

The vaginal microbiome may impact the efficacy of HIV prevention therapy

The vaginal microbiome may impact the efficacy of HIV prevention therapy

HIV 'wonder drug' may not be as effective as hoped in sub-Saharan Africa, study suggests

HIV 'wonder drug' may not be as effective as hoped in sub-Saharan Africa, study suggests

SEAR implemented measures for successful continuation of essential HIV services during COVID 19

SEAR implemented measures for successful continuation of essential HIV services during COVID 19

Researchers successfully edit SIV virus from genomes of non-human primates

Researchers successfully edit SIV virus from genomes of non-human primates

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

Cabotegravir highly effective in preventing HIV among women

Cabotegravir highly effective in preventing HIV among women

Trial results show CAB LA is more effective in preventing HIV acquisition in women

Trial results show CAB LA is more effective in preventing HIV acquisition in women

Study identifies new cause of inflammation in people living with HIV

Study identifies new cause of inflammation in people living with HIV

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Study: Antiretroviral therapy fails to restore age-appropriate epigenetic patterns

Study: Antiretroviral therapy fails to restore age-appropriate epigenetic patterns

NIH awards $1.6 million for research on hormonal control of HIV latency

NIH awards $1.6 million for research on hormonal control of HIV latency